---
title: "CQP: As of the end of October, a total of RMB 80.9988 million has been spent to repurchase shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264034818.md"
description: "CQP announced that the company plans to repurchase shares in July 2025, with a total funding amount of 80 million to 100 million yuan, and the repurchase price not exceeding 6.6 yuan per share, with a duration of 12 months. As of October 31, the company has cumulatively repurchased 15.4066 million shares, accounting for 0.8915% of the total share capital, with a highest transaction price of 5.48 yuan per share and a lowest of 5.01 yuan per share, totaling a payment amount of 80.9988 million yuan. The company will continue to implement the repurchase according to the plan and disclose information in a timely manner"
datetime: "2025-11-03T13:15:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264034818.md)
  - [en](https://longbridge.com/en/news/264034818.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264034818.md)
---

# CQP: As of the end of October, a total of RMB 80.9988 million has been spent to repurchase shares

CQP announced that the company will repurchase shares in July 2025, with a total funding amount of 80 million to 100 million yuan, and the repurchase price not exceeding 6.6 yuan per share, with a duration of 12 months. As of October 31, the company has cumulatively repurchased 15.4066 million shares, accounting for 0.8915% of the total share capital, with a highest transaction price of 5.48 yuan per share and a lowest of 5.01 yuan per share, totaling a payment amount of 80.9988 million yuan. The company will continue to implement the repurchase according to the plan and disclose information in a timely manner

### Related Stocks

- [000950.CN](https://longbridge.com/en/quote/000950.CN.md)

## Related News & Research

- [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [Palfinger wins Dragados order for seven davit cranes for North Sea HVDC platforms](https://longbridge.com/en/news/287017946.md)
- [Poxel wins Japan patent for imeglimine use in type 2 diabetes patients with renal impairment](https://longbridge.com/en/news/287013341.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)